Equity Research Education & Training Services

Should You Buy iHuman Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 10/13 models active

According to the CirclFi Deep Alpha Valuation Engine, iHuman Inc. (IH) is rated as a strong fundamental performer with a QOC score of 8.6/10. Trading at $1.16, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 10 of 10 CirclFi valuation models project upside for iHuman Inc. (IH) at $1.16 — the model consensus leans bullish, with a Quality Score of 8.6/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 10 of 10 models see upside — majority bullish
  • Quality Score: 8.6/10 — Excellent — top-tier fundamentals
  • Value Trap Risk: 12/100 — Minimal — healthy fundamentals
  • Fair Value Range: $3.07 – $6.87 (124% spread)

Bullish Models

10 / 10

Bearish Models

0 / 10

Quality Score

8.6 /10

Excellent — top-tier fundamentals

Value Trap Risk

12 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

10 /13
Active Models

Avg. confidence: 41%

What Is the Investment Case for iHuman Inc. (IH) in 2026?

What Is the Bull Case vs the Bear Case for iHuman Inc. (IH)?

Bull case versus bear case for iHuman Inc. (IH) at $1.16, derived from 10 active CirclFi valuation models on 2026-09-15.
Bull case — $6.87 target (+492.1%) Bear case
According to the CirclFi Quality of Company (QOC) framework, iHuman Inc.'s score of 8.6/10 reflects durable competitive advantages that should sustain earnings power through market cycles. No active model flags significant downside for IH. The low Value Trap score paints a constructive picture.
According to the CirclFi Deep Alpha Valuation Engine, the stock shows multi-model upside with a median implied return of +297.5% across 10 bullish models from the current price of $1.16.
According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model targets a fair value of $6.87 (+492.1%), anchoring the bull case with a methodology that provides a differentiated analytical lens.

How Does IH Compare to Its Education & Training Services Peers?

LAUR Laureate Education,
8.7
STG Sunlands Technology
8.6
CVSA Covista Inc.
8.8
AFYA Afya Limited
8.5
UTI Universal Technical
9.1
APEI American Public Educ
8.5
LINC Lincoln Educational
7.6
JDZG JIADE Limited
6.1

Valuation data pages: LAUR · STG · CVSA · AFYA · UTI · APEI · LINC · JDZG · LXEH · LRN

Which Other Stocks Score Like IH on Quality?

Closest companies to IH’s Quality of Company score of 8.6/10, across all industries.

Why Do CirclFi’s 10 Models Disagree on IH?

Spread

124%

Fair Value Range

$3.07 – $6.87

A 124% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

RCMH-DCF

$6.87 (+492.1%)

Most Bearish

Dynamic NAV

$3.07 (+164.8%)

What Are the Biggest Risks of Buying IH Stock?

Model Disagreement

124% spread signals high variance in projections.

Macro/Sector Risk

Education & Training Services headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View IH Data Page →

So Is iHuman Inc. (IH) Worth Buying in 2026?

iHuman Inc. at $1.16 presents what our engine identifies as a high-conviction opportunity: 10 of 10 models see upside, quality stands at 8.6/10, and the median fair value of $4.61 implies +297.5% return potential. Investors should verify this thesis against their own risk parameters and time horizon.

These are quantitative model outputs, not investment recommendations. iHuman Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About IH Stock?

Should I buy IH stock right now?

Based on CirclFi's multi-model analysis, 10 of 10 models see upside for IH at $1.16. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 8.6/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in iHuman Inc.?

Key risks include: wide model disagreement (124% spread), signaling high uncertainty; general market and sector-specific risks affecting Education & Training Services companies. Always diversify and consult a financial advisor.

How does IH compare to its competitors?

Among Education & Training Services peers, IH holds a Quality Score of 8.6/10. Comparable companies include LAUR (QOC 8.7), STG (QOC 8.6), CVSA (QOC 8.8). The relative ranking helps investors identify whether IH offers better fundamental quality than alternatives in the same sector.

Is IH a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. IH's Quality Score of 8.6/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy IH at?

CirclFi does not provide target buy prices or price alerts. However, our 10 active models produce fair value estimates ranging from $3.07 to $6.87. At $1.16, the stock trades below even the most conservative estimate, which may represent a margin of safety — or reflect risks the models don't capture. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for IH.

View IH Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →